⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockIsraelNasdaqCM

PYPD

PolyPid Ltd.

Healthcare · Biotechnology

5.25USD

+0.1200 (+2.34%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on PYPD.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Calls on PYPD

  • @VIC_BOT · Sep 9, 2026BUY

    Buy PYPD at $3.90

    Imported from Value Investors Club — styx1003

    +34.6%

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.27▲-$0.3210
Next quarter-$0.41▼-$0.3413
Current year-$0.89▲-$1.4310
Next year-$1.23▲-$1.2622

Recent quarters

Beat in 3 of the last 4

QuarterEstimateActualSurprise
2026-06-30-$0.38-$0.35+0.03 (+7.3%)
2026-03-31-$0.43-$0.35+0.08 (+19.2%)
2025-12-31-$0.33-$0.41-0.08 (-24.2%)
2025-09-30-$0.52-$0.37+0.15 (+29.2%)

Wall Street coverage

30 ratings from 9 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
HC Wainwright & Co.ReiteratedBuy$13Jul 21, 2026
HC Wainwright & Co.ReiteratedBuy$13Feb 11, 2026
Roth CapitalMaintainedBuy$10 $9Nov 13, 2025
Craig-HallumMaintainedBuy$15 $13Aug 14, 2025
HC Wainwright & Co.ReiteratedBuy$13Aug 13, 2025
Roth CapitalMaintainedBuy$12 $9Jun 18, 2025
JMP SecuritiesMaintainedMarket Outperform$16 $14Jun 17, 2025
HC Wainwright & Co.MaintainedBuy$11 $13Jun 9, 2025
Roth CapitalInitiatedBuy$9Jun 5, 2025
HC Wainwright & Co.ReiteratedBuy$11Apr 14, 2025
HC Wainwright & Co.MaintainedBuy$14 $11Dec 26, 2024
HC Wainwright & Co.ReiteratedBuy$14Dec 16, 2024
Craig-HallumInitiatedBuy$10Nov 4, 2024
HC Wainwright & Co.ReiteratedBuy$14Oct 2, 2024
HC Wainwright & Co.ReiteratedBuy$14Aug 15, 2024
HC Wainwright & Co.ReiteratedBuy$14Jun 18, 2024
HC Wainwright & Co.ReiteratedBuy$14May 9, 2024
HC Wainwright & Co.ReiteratedBuy$14May 1, 2024
BarclaysMaintainedEqual-Weight$2.5 $10Oct 23, 2023
HC Wainwright & Co.InitiatedBuy$16Oct 12, 2023
BarclaysDowngraded from OverweightEqual-Weight$22 $2.5Sep 7, 2022
Raymond JamesDowngraded from Strong BuyOutperform$15 $4Sep 6, 2022
BMO CapitalMaintainedOutperform$27 $25Aug 11, 2022
Raymond JamesMaintainedStrong Buy$23 $17Feb 11, 2022
JMP SecuritiesInitiatedMarket Outperform$14Sep 14, 2021

Analyst Notes

Sign in to write
  • @VIC_BOT wrote a note on PYPD · Sep 9, 2026Buy

    POLYPID LTD (PYPD)

    0 likes · 0 comments

Analyst Ratings

4 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current13000Buy1.75
1 mo ago13000Buy1.75
2 mo ago13000Buy1.75
Price target$11.75$8.00 – $14.00
+123.8% to target

Top voices on PYPD

Members whose judged calls on PYPD have played out most reliably.

No settled calls on PYPD yet. 1 call is open, the first due Sep 9, 2027.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice